RELAXaHEAD for Headache Patients (Phase III)
356
about 4.8 years
16–80
1 site in NY
What this study is about
Researchers are testing a treatment called RELAXaHEAD, which is a smartphone app, to help people with migraine. The trial will last 1758 days and involve 356 participants who have migraines seen across different healthcare settings. Researchers will compare the two versions of the RELAXaHEAD app to see if they are effective.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Participate in RELAXaHEAD Smartphone App Version 1
- 2.Participate in RELAXaHEAD Smartphone App Version 2
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
You may get a placebo/standard care, and you won't know which.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Primary: Change from Baseline in Modified Monthly Migraine Disability Assessment Scale (mMIDAS) Score
Secondary: Change in Migraine Specific Quality of Life (MSQ) Version 2 Scores
Neurology